Visarius T M, Putt D A, Schare J M, Pegouske D M, Lash L H
Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Biochem Pharmacol. 1996 Jul 26;52(2):259-72. doi: 10.1016/0006-2952(96)00203-1.
Cellular uptake and metabolism of exogenous glutathione (GSH) in freshly isolated proximal tubular (PT) cells from rat kidney were examined in the absence and presence of inhibitors of GSH turnover [acivicin, L-buthionine-S,R-sulfoximine (BSO)] to quantify and assess the role of different pathways in the handling of GSH in this renal cell population. Incubation of PT cells with 2 or 5 mM GSH in the presence of acivicin/BSO produced 3- to 4-fold increases in intracellular GSH within 10-15 min. These significantly higher intracellular concentrations were maintained for up to 60 min. At lower concentrations of extracellular GSH, an initial increase in intracellular GSH concentrations was observed, but this was not maintained for the 60-min time course. In the absence of inhibitors, intracellular concentrations of GSH increased to levels that were 2- to 3-fold higher than initial values in the first 10-15 min, but these dropped below initial levels thereafter. In both the absence and presence of acivicin/BSO, PT cells catalyzed oxidation of GSH to glutathione disulfide (GSSG) and degradation of GSH to glutamate and cyst(e)ine. Exogenous tert-butyl hydroperoxide oxidized intracellular GSH to GSSG in a concentration-dependent manner and extracellular GSSG was transported into PT cells, but limited intracellular reduction of GSSG to GSH occurred. Furthermore, incubation of cells with precursor amino acids produced little intracellular synthesis of GSH, suggesting that PT cells have limited biosynthetic capacity for GSH under these conditions. Hence, direct uptake of GSH, rather than reduction of GSSG or resynthesis from precursors, may be the primary mechanism to maintain intracellular thiol redox status under toxicological conditions. Since PT cells are a primary target for toxicants, the ability of these cells to rapidly take up and metabolize GSH may serve as a defensive mechanism to protect against chemical injury.
在不存在和存在谷胱甘肽(GSH)周转抑制剂[阿西维辛、L-丁硫氨酸-S,R-亚砜亚胺(BSO)]的情况下,检测了从大鼠肾脏新鲜分离的近端肾小管(PT)细胞中外源性GSH的细胞摄取和代谢情况,以量化和评估不同途径在该肾细胞群体中处理GSH的作用。在阿西维辛/BSO存在的情况下,将PT细胞与2或5 mM GSH孵育,10 - 15分钟内细胞内GSH增加3至4倍。这些显著更高的细胞内浓度可维持长达60分钟。在较低浓度的细胞外GSH情况下,观察到细胞内GSH浓度最初有所增加,但在60分钟的时间进程中并未维持。在不存在抑制剂的情况下,细胞内GSH浓度在最初的10 - 15分钟内增加到比初始值高2至3倍的水平,但此后降至初始水平以下。在不存在和存在阿西维辛/BSO的情况下,PT细胞都催化GSH氧化为谷胱甘肽二硫化物(GSSG)以及GSH降解为谷氨酸和半胱氨酸。外源性叔丁基过氧化氢以浓度依赖的方式将细胞内GSH氧化为GSSG,并且细胞外GSSG被转运到PT细胞中,但细胞内将GSSG还原为GSH的过程有限。此外,用前体氨基酸孵育细胞产生的细胞内GSH合成很少,这表明在这些条件下PT细胞合成GSH的能力有限。因此,在毒理学条件下,直接摄取GSH,而不是还原GSSG或从前体重新合成,可能是维持细胞内硫醇氧化还原状态的主要机制。由于PT细胞是毒物的主要靶标,这些细胞快速摄取和代谢GSH的能力可能作为一种防御机制来防止化学损伤。